Concepts (135)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Schistosomiasis japonica | 2 | 2020 | 6 | 0.810 |
Why?
|
| Colitis | 1 | 2022 | 172 | 0.680 |
Why?
|
| Colitis, Ulcerative | 1 | 2022 | 218 | 0.640 |
Why?
|
| Colonic Neoplasms | 1 | 2022 | 267 | 0.630 |
Why?
|
| Mitochondria | 2 | 2019 | 752 | 0.530 |
Why?
|
| Neoplasms | 2 | 2022 | 2975 | 0.530 |
Why?
|
| Apoptosis | 1 | 2022 | 1928 | 0.470 |
Why?
|
| Liver Cirrhosis | 2 | 2020 | 898 | 0.410 |
Why?
|
| Death-Associated Protein Kinases | 2 | 2022 | 6 | 0.390 |
Why?
|
| Actins | 2 | 2022 | 341 | 0.300 |
Why?
|
| Inflammasomes | 2 | 2020 | 170 | 0.270 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2022 | 170 | 0.220 |
Why?
|
| Schistosoma japonicum | 2 | 2020 | 10 | 0.200 |
Why?
|
| Ephrins | 1 | 2022 | 5 | 0.200 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2023 | 91 | 0.200 |
Why?
|
| Gene Expression | 3 | 2022 | 1598 | 0.200 |
Why?
|
| Hyperplasia | 1 | 2022 | 202 | 0.190 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2022 | 66 | 0.180 |
Why?
|
| Communication Barriers | 1 | 2021 | 42 | 0.180 |
Why?
|
| Masks | 1 | 2021 | 40 | 0.180 |
Why?
|
| Professional-Patient Relations | 1 | 2021 | 93 | 0.170 |
Why?
|
| Mice, Inbred BALB C | 2 | 2020 | 1072 | 0.170 |
Why?
|
| Strongylida Infections | 1 | 2020 | 15 | 0.160 |
Why?
|
| Meningoencephalitis | 1 | 2020 | 22 | 0.160 |
Why?
|
| Collagen Type III | 1 | 2019 | 26 | 0.160 |
Why?
|
| Breast Neoplasms | 2 | 2023 | 2745 | 0.160 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2019 | 47 | 0.160 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2019 | 46 | 0.160 |
Why?
|
| Medulloblastoma | 1 | 2024 | 571 | 0.160 |
Why?
|
| Interleukin-17 | 1 | 2020 | 130 | 0.160 |
Why?
|
| Collagen Type I | 1 | 2019 | 124 | 0.150 |
Why?
|
| Glioblastoma | 1 | 2023 | 373 | 0.150 |
Why?
|
| Shiga Toxin | 1 | 2018 | 2 | 0.150 |
Why?
|
| Caspases, Initiator | 1 | 2018 | 6 | 0.150 |
Why?
|
| Pregnancy Outcome | 1 | 2022 | 636 | 0.150 |
Why?
|
| Tail | 1 | 2018 | 14 | 0.140 |
Why?
|
| Myosin Light Chains | 1 | 2018 | 18 | 0.140 |
Why?
|
| Microfluidics | 1 | 2018 | 28 | 0.140 |
Why?
|
| Myosin-Light-Chain Kinase | 1 | 2018 | 67 | 0.140 |
Why?
|
| Intestines | 1 | 2022 | 613 | 0.140 |
Why?
|
| Vasoconstriction | 1 | 2018 | 98 | 0.140 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2018 | 128 | 0.140 |
Why?
|
| Lipopolysaccharides | 1 | 2018 | 308 | 0.130 |
Why?
|
| Health Personnel | 1 | 2021 | 546 | 0.130 |
Why?
|
| Mass Spectrometry | 1 | 2018 | 366 | 0.130 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2018 | 240 | 0.130 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2022 | 955 | 0.130 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2018 | 382 | 0.120 |
Why?
|
| Genome, Human | 3 | 2024 | 1336 | 0.120 |
Why?
|
| Reactive Oxygen Species | 1 | 2018 | 520 | 0.120 |
Why?
|
| Single-Cell Analysis | 1 | 2018 | 356 | 0.110 |
Why?
|
| Neoplasm Proteins | 1 | 2018 | 713 | 0.110 |
Why?
|
| Peptide Fragments | 1 | 2018 | 811 | 0.110 |
Why?
|
| Brain Neoplasms | 1 | 2023 | 1408 | 0.100 |
Why?
|
| Biomarkers, Tumor | 1 | 2022 | 1690 | 0.100 |
Why?
|
| Humans | 13 | 2024 | 133242 | 0.100 |
Why?
|
| Liver | 1 | 2020 | 1852 | 0.100 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2018 | 571 | 0.100 |
Why?
|
| Sequence Analysis, DNA | 1 | 2018 | 1825 | 0.090 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2024 | 2115 | 0.090 |
Why?
|
| T-Lymphocytes | 1 | 2020 | 1770 | 0.090 |
Why?
|
| Genetic Variation | 2 | 2008 | 1594 | 0.090 |
Why?
|
| Animals | 6 | 2024 | 35916 | 0.080 |
Why?
|
| Chromatin | 2 | 2023 | 622 | 0.080 |
Why?
|
| Pyroptosis | 2 | 2020 | 27 | 0.080 |
Why?
|
| Population | 1 | 2008 | 24 | 0.070 |
Why?
|
| Brain | 1 | 2020 | 3216 | 0.070 |
Why?
|
| Chromosomes, Human | 1 | 2008 | 132 | 0.070 |
Why?
|
| Quantitative Trait Loci | 1 | 2007 | 314 | 0.060 |
Why?
|
| Cisplatin | 1 | 2007 | 284 | 0.060 |
Why?
|
| Cell Line, Tumor | 2 | 2023 | 3781 | 0.060 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2008 | 2858 | 0.060 |
Why?
|
| Male | 5 | 2024 | 65435 | 0.050 |
Why?
|
| Cell Line | 3 | 2018 | 2830 | 0.050 |
Why?
|
| New Zealand | 1 | 2022 | 60 | 0.050 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2023 | 249 | 0.050 |
Why?
|
| Australia | 1 | 2022 | 192 | 0.050 |
Why?
|
| Neoplastic Stem Cells | 1 | 2023 | 351 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2020 | 31 | 0.040 |
Why?
|
| Angiostrongylus cantonensis | 1 | 2020 | 9 | 0.040 |
Why?
|
| CD11b Antigen | 1 | 2020 | 39 | 0.040 |
Why?
|
| Cerebellar Neoplasms | 1 | 2024 | 461 | 0.040 |
Why?
|
| Mice | 3 | 2024 | 18888 | 0.040 |
Why?
|
| Breast Feeding | 1 | 2022 | 240 | 0.040 |
Why?
|
| Time-to-Treatment | 1 | 2022 | 211 | 0.040 |
Why?
|
| Schistosomiasis | 1 | 2020 | 54 | 0.040 |
Why?
|
| Granuloma | 1 | 2020 | 66 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2020 | 4818 | 0.040 |
Why?
|
| Histones | 1 | 2023 | 572 | 0.040 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2020 | 211 | 0.040 |
Why?
|
| Phosphate-Binding Proteins | 1 | 2018 | 11 | 0.040 |
Why?
|
| Cesarean Section | 1 | 2022 | 403 | 0.040 |
Why?
|
| Calcium-Binding Proteins | 1 | 2020 | 336 | 0.040 |
Why?
|
| Marine Toxins | 1 | 2018 | 7 | 0.040 |
Why?
|
| Clonal Evolution | 1 | 2018 | 49 | 0.040 |
Why?
|
| Oxazoles | 1 | 2018 | 23 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2018 | 302 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2023 | 766 | 0.030 |
Why?
|
| Transcriptome | 1 | 2024 | 1134 | 0.030 |
Why?
|
| DNA Methylation | 1 | 2024 | 1140 | 0.030 |
Why?
|
| Premature Birth | 1 | 2022 | 417 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2007 | 1849 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2018 | 630 | 0.030 |
Why?
|
| Communication | 1 | 2021 | 543 | 0.030 |
Why?
|
| Vasoconstrictor Agents | 1 | 2018 | 140 | 0.030 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2018 | 126 | 0.030 |
Why?
|
| Proteolysis | 1 | 2018 | 200 | 0.030 |
Why?
|
| Arteries | 1 | 2018 | 229 | 0.030 |
Why?
|
| Female | 4 | 2024 | 71474 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2018 | 589 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2018 | 596 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2018 | 1245 | 0.030 |
Why?
|
| Incidence | 1 | 2022 | 3376 | 0.030 |
Why?
|
| Macrophages | 1 | 2018 | 698 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2018 | 1663 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 3749 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2018 | 3124 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2020 | 3978 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2022 | 6579 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 3047 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 4725 | 0.020 |
Why?
|
| Pregnancy | 1 | 2022 | 7593 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2022 | 8635 | 0.020 |
Why?
|
| Epoxide Hydrolases | 1 | 2008 | 37 | 0.020 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2007 | 91 | 0.020 |
Why?
|
| Young Adult | 1 | 2021 | 9976 | 0.020 |
Why?
|
| Haplotypes | 1 | 2008 | 545 | 0.020 |
Why?
|
| United States | 1 | 2021 | 11659 | 0.020 |
Why?
|
| Mutation | 1 | 2018 | 6314 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2007 | 1059 | 0.010 |
Why?
|
| Computational Biology | 1 | 2008 | 883 | 0.010 |
Why?
|
| Middle Aged | 1 | 2021 | 29026 | 0.010 |
Why?
|
| Genotype | 1 | 2007 | 2718 | 0.010 |
Why?
|
| Adult | 1 | 2021 | 31746 | 0.010 |
Why?
|
| Aged | 1 | 2018 | 21486 | 0.010 |
Why?
|